| Dr David Alan Mccarron, | |
|
120 Nw 9th Ave, Suite 206, Portland, OR 97209-3324 | |
| (503) 957-0511 | |
| Not Available |
| Full Name | Dr David Alan Mccarron |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Nephrology |
| Location | 120 Nw 9th Ave, Portland, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386074953 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | MD10925 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Alan Mccarron, 120 Nw 9th, Suite 206, Portland, OR 97209 Ph: (503) 957-0511 | Dr David Alan Mccarron, 120 Nw 9th Ave, Suite 206, Portland, OR 97209-3324 Ph: (503) 957-0511 |
News Archive
Research presented at the Academy of Managed Care Pharmacy (AMCP) Nexus in early October in Washington, DC, showed that 60 percent of adult patients who were diagnosed with primary headache had one or more comorbidities which raised the average annual cost of their healthcare to over $20,000.
Priority Health, one of the nation's top health plans, is pleased to recognize 138 primary care practices across the state of Michigan with the Priority Health Quality Awards. The Priority Health Quality Awards were established in 2003 to recognize excellence in health care. Quality Awards are presented in two categories: Exceptional Patient Care and Outstanding Health Care Value. Among the honorees are 38 practices winning awards in both categories.
As part of a multicenter clinical trial, researchers at University of California, San Diego School of Medicine are evaluating Pexa-Vec (JX-594) to slow the progression of hepatocellular carcinoma or liver cancer. Pexa-Vec is a genetically engineered virus that is used in the smallpox vaccine.
Eight people with long-term paralysis from spinal cord injuries have regained some motor control after learning to control their own brain activity.
The Multiple Myeloma Research Foundation (MMRF) today announced that it has awarded $1 million to each of three Boston-area biotech companies through its 2010 Biotech Investment Awards program: Constellation Pharmaceuticals, Inc., Epizyme, Inc. and Karyopharm Therapeutics, Inc. Since the inception of this MMRF program in 2006, $11 million has been committed to 11 biotech companies in multi-year, results-driven funding for the development of innovative treatments for patients with multiple myeloma.
› Verified 2 days ago
Salona Shrestha, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4805 Ne Glisan St, Portland, OR 97213 Phone: 503-215-2392 | |
Dr. Emmanuel Trungtoan Tavan, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2800 N Vancouver Ave, Suite 230, Portland, OR 97227 Phone: 503-413-2901 | |
Ginevra Lois Liptan, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 6400 Sw Canyon Ct, Ste 100, Portland, OR 97221 Phone: 503-477-9616 Fax: 503-477-9808 | |
Donald Richard Sullivan, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Uhn67, Portland, OR 97239 Phone: 503-494-6949 | |
Dr. Victor Nguyen Pham, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 9205 Sw Barnes Rd, Portland, OR 97225 Phone: 503-216-2906 | |
Richa Uppal, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 800 Sw 13th Ave, Portland, OR 97205 Phone: 503-221-0161 Fax: 503-274-1697 | |
Reem Hasan, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Ppv 350, Portland, OR 97239 Phone: 503-494-8562 |